.
New Delhi, April 26 (MondayMirror.com) The Drugs Controller General of India (DCGI) on Tuesday approved the restricted emergency use authorisation (EUA) to Bharat Biotech’s Covaxin for children between the age of 6-12 years, sources said.
The DGCI has asked vaccine manufacturer to submit safety data including the data on adverse event with due analysis every 15 days for the first two months and monthly thereafter upto 5 months, said the source familiar with the development.
This development comes after the Subject Expert Committee (SEC) discussed recommendations for the restricted emergency use of Covaxin in children aged between 2-12 years.
However, the SEC, after a meeting on Thursday, had recommended restricted emergency use of Biological E’s Covid-19 vaccine, Corbevax, in children aged 5-12 years.
Source: IANS
For decades, Bollywood movies followed a familiar formula. A heroic protagonist fought against a clearly…
Celebrity weddings in India are no longer just private celebrations between two individuals. Over the…
For decades, Bollywood operated on a simple formula: cast a major superstar, launch an aggressive…
The Bollywood industry in 2026 is witnessing a clear trend: sequels are everywhere. From highly…
Nineteen-year-old actor, film director & author - Nikasha Luthra, has announced the unveiling of her…
The Indian entertainment industry is currently witnessing one of its most significant discussions in recent…